Summary of Study ST001215
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000811. The data can be accessed directly via it's Project DOI: 10.21228/M8VD62 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST001215 |
Study Title | Effect of Mirabegron Treatment on serum lipidome |
Study Summary | Determine the lipidome changes in the serum of human subjects treated with a single dosage (200mg) of the beta-3 adrenoceptor agonist Mirabegron. |
Institute | Joslin Diabetes Center |
Last Name | Leiria |
First Name | Luiz |
Address | One Joslin Place, 02215, Boston, MA-USA |
luiz.leiria@joslin.harvard.edu | |
Phone | 617-309-1967 |
Submit Date | 2016-10-23 |
Raw Data Available | Yes |
Raw Data File Type(s) | wiff |
Analysis Type Detail | LC-MS |
Release Date | 2019-09-23 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Treatment |
---|---|---|
SA085891 | 309-14 M | Mirabegron |
SA085892 | 309-17 M | Mirabegron |
SA085893 | 309-18 M | Mirabegron |
SA085894 | 309-13 M | Mirabegron |
SA085895 | 309-15 M | Mirabegron |
SA085896 | 309-05 M | Mirabegron |
SA085897 | 309-12 M | Mirabegron |
SA085898 | 309-06 M | Mirabegron |
SA085899 | 309-02 M | Mirabegron |
SA085900 | 309-04 M | Mirabegron |
SA085901 | 309-03 M | Mirabegron |
SA085902 | 309-13 P | Placebo |
SA085903 | 309-12 P | Placebo |
SA085904 | 309-02 P | Placebo |
SA085905 | 309-18 P | Placebo |
SA085906 | 309-15 P | Placebo |
SA085907 | 309-04 P | Placebo |
SA085908 | 309-17 P | Placebo |
SA085909 | 309-03 P | Placebo |
SA085910 | 309-14 P | Placebo |
SA085911 | 309-05 P | Placebo |
SA085912 | 309-06 P | Placebo |
Showing results 1 to 22 of 22 |